Geron (GERN) Times Interest Earned (2010 - 2026)
Geron (GERN) posted Times Interest Earned of $0.02 for Q1 2026, up 100.63% sequentially from -$3.5 in Q4 2025, and up 101.09% YoY from $0.01 in Q1 2025.
Geron (GERN) Times Interest Earned (2010 - 2026) Analysis & Trends
Geron has reported Times Interest Earned for 17 years, with the latest figure at $0.02 in Q1 2026.
- Quarterly Times Interest Earned rose 101.09% year-over-year to $0.02 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.64 (up 71.64% YoY) and the FY2025 annual result came in at -$0.15, up 61.83% from the prior year.
- Times Interest Earned improved to $0.02 in Q1 2026 per GERN's latest filing, from -$3.5 in the prior quarter.
- Over five years, Times Interest Earned peaked at $0.02 in Q1 2026 and troughed at -$151.45 in Q4 2022.
- A 5-year average of -$22.98 and a median of -$17.7 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2026: Times Interest Earned sank 403.88% in 2022, then soared 101.09% in 2026.
- Over 5 years, Times Interest Earned stood at -$151.45 in 2022, then surged by 65.06% to -$52.91 in 2023, then soared by 95.65% to -$2.3 in 2024, then slumped by 51.98% to -$3.5 in 2025, then soared by 100.63% to $0.02 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $0.02, -$3.5, and -$1.61 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - | -1.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.75 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | -3.50 |
| Sep 30, 2025 | -1.61 |
| Jun 30, 2025 | -1.46 |
| Mar 31, 2025 | -2.04 |
| Dec 31, 2024 | -2.30 |
| Sep 30, 2024 | -9.26 |
| Jun 30, 2024 | -20.89 |
| Mar 31, 2024 | -16.35 |
| Dec 31, 2023 | -52.91 |
| Sep 30, 2023 | -23.05 |
| Jun 30, 2023 | -25.94 |
| Mar 31, 2023 | -20.86 |
| Dec 31, 2022 | -151.45 |
| Sep 30, 2022 | -21.99 |
| Jun 30, 2022 | -17.70 |
| Mar 31, 2022 | -19.39 |
| Dec 31, 2021 | -312.95 |
| Sep 30, 2021 | -24.27 |